検索結果

产品开发方针 | 研究与开发 | 千寿制药株式会社

s T, et al. RNA-Seq-based transcriptome analysis of corneal endothelial cells derived from patients with Fuchs endothelial corneal dystrophy. Sci Rep. 2023;13(1):8647.  #6: Krachmer JH, Purcell JJ Jr,...

学会発表実績 | 研究開発活動 | 千寿製薬株式会社

開催地：Salt Lake City, Utah, United States of America Establishment of in vitro drug evaluation model with retinal ganglion cells from Leber’s hereditary optic neuropathy (LHON) patient-derived iPSC R.I...

お知らせ | 千寿製薬株式会社

e formulation of Aibeta® combination eye drops（PDF） 2025年03月07日 Announcement of Licensing Agreement with Brill International（PDF） 2025年02月20日 Launch and Distribution of “MIEr for BeelineMED”（PDF） 2025...

发表论文 | 研究与开发 | 千寿制药株式会社

y Medicine and Science, 10(6), 2024 Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction Jun Shimazaki 1,2, Gakushi Kito 3, Mizuka Kamoi 2, ...

arpening algorithm. We aim to promote “more visibility” by providing products and services equipped with image sharpening and high-resolution algorithms in the future, emphasizing the importance of si...